Short communicationNeuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats
Section snippets
Acknowledgements
Funded by grants to VLRR (American Heart Association National, 9950086N; American Heart Association Wisconsin Affiliate, 9806376X; the UW-Madison Medical School Research Committee, 161-9587 and the Department of Neurological Surgery, UW-Madison Start-up) and to RJD (National Institute of Health, NS28000 and NS31220).
References (30)
- et al.
Memantine reduces functional and morphological consequences induced by global ischemia in rats
Neurosci. Lett.
(1996) - et al.
Neuroprotective concentrations of the N-methyl-d-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation
Neuroscience
(1998) - et al.
Memantine for prevention of spinal cord injury in a rabbit model
J. Thorac. Cardiovasc. Surg.
(1999) - et al.
Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-d-aspartate
Eur. J. Pharmacol.
(1991) - et al.
Psychotogenicity and N-methyl-d-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy
Biol. Psychol.
(1997) - et al.
Neuroprotection by memantine as increased by hypothermia and nimodipine
Eur. J. Pharm. Sci.
(1997) - et al.
Excitatory amino acid receptor subtype binding following traumatic brain injury
Brain Res.
(1990) - et al.
Memantine is a clinically well-tolerated N-methyl-d-aspartate (NMDA) receptor antagonist — a review of preclinical data
Neuropharmacology
(1999) - et al.
Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat
Eur. J. Pharmacol.
(1999) - et al.
Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity
J. Neurosci.
(1992)
Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat
J. Neurotrauma
(1998)
Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats
Acta Neurochir.
(1999)
Clinical neuroprotection trials in severe traumatic brain injury: lessons from previous studies
J. Neurotrauma
(1997)
Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms — new results of clinical studies
Fortschr. Neurol. Psychiatr.
(1997)
Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study
Pharm. Res.
(1999)
Cited by (113)
Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
2024, Journal of Controlled ReleaseBridging the gap: Mechanisms of plasticity and repair after pediatric TBI
2019, Experimental NeurologyEffect of Yokukansan on Nitric Oxide Production and Hydroxyl Radical Metabolism During Cerebral Ischemia and Reperfusion in Mice
2019, Journal of Stroke and Cerebrovascular Diseases
Copyright © 2001 Elsevier Science B.V. All rights reserved.